Advanced PRAME Positive Solid Tumors research hub

A study testing a new treatment called TK-6302 for the first time in people with advanced cancers that have a genetic marker called HLA-A02:01 and a tumour protein called PRAME.

This study is testing a new medicine, TK-6302, for advanced cancers that have specific markers. It's the first time this medicine is being given to people, to check if it's safe and how it works. Researchers hope it could offer a new way to fight these cancers.